Clinical Trial Update: Advair HFA For Chronic Obstructive Pulmonary Disease(COPD) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Advair HFA in chronic obstructive pulmonary disease; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Advair HFA (fluticasone propionate/salmeterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED | Results posted: 2009-11-26